A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1 (ILLUMINATE-B)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03905694

Recruitment Status : Active, not recruiting

First Posted : April 5, 2019

Last Update Posted : February 5, 2021

Sponsor:

Information provided by (Responsible Party):

Alnylam Pharmaceuticals

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Actual Primary Completion Date :	June 29, 2020
Estimated Study Completion Date :	August 19, 2024

To Top